Pierre Caloz
Chief Operating Officer presso UNIQURE N.V.
Patrimonio netto: 616 944 $ in data 31/03/2024
Profilo
Pierre Caloz is currently the Chief Operating Officer at uniQure NV since 2021.
Prior to this, he worked as the SVP, GM-European Union & Asia Pacific Operations at CSL Behring NV.
Caloz completed his undergraduate degree from the University of Geneva in 1996, followed by a graduate degree from the Swiss Federal Institute of Technology in 1997.
He also holds an MBA from Ashridge Business School, which he completed in 2010.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
UNIQURE N.V.
0.25% | 01/03/2024 | 118 643 ( 0.25% ) | 616 944 $ | 31/03/2024 |
Posizioni attive di Pierre Caloz
| Società | Posizione | Inizio |
|---|---|---|
| UNIQURE N.V. | Chief Operating Officer | 17/05/2021 |
Precedenti posizioni note di Pierre Caloz
| Società | Posizione | Fine |
|---|---|---|
CSL Behring NV
 CSL Behring NV BiotechnologyHealth Technology CSL Behring NV engages in the research and development of biotherapies for the treatment of rare and severe illnesses. It offers hematology, immunology, pneumology and specific medicine. The company was founded on February 15, 1995 and is headquartered in Mechelen, Belgium. | Corporate Officer/Principal | - |
Formazione di Pierre Caloz
| University of Geneva | Undergraduate Degree |
| Swiss Federal Institute of Technology | Graduate Degree |
| Ashridge Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| UNIQURE N.V. | Health Technology |
| Aziende private | 1 |
|---|---|
CSL Behring NV
CSL Behring NV BiotechnologyHealth Technology CSL Behring NV engages in the research and development of biotherapies for the treatment of rare and severe illnesses. It offers hematology, immunology, pneumology and specific medicine. The company was founded on February 15, 1995 and is headquartered in Mechelen, Belgium. | Health Technology |
- Borsa valori
- Insiders
- Pierre Caloz
